.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Medication Therapy Management implementation is a vital strategy for improving patient safety in complex clinical areas like oncology. However, a recent study in Kenya highlights a significant gap between the high perceived value of these services and their actual availability in clinical practice. Moreover, findings showed that while over 90% of participants believed MTM would reduce toxicities, only about 24% understood the service. Consequently, this lack of awareness, combined with severe staffing shortages and inadequate funding, creates a bottleneck in delivering high-quality cancer care. In addition, the research surveyed 450 participants, including patients, caregivers, and professionals across four cancer care centres. Furthermore, the results indicated that 86.9% of participants reported MTM services as currently unavailable.
Therefore, healthcare systems must prioritize workforce capacity and sustainable financing to institutionalize medication safety. Specifically, bridging the gap requires competency-based training and digitally enabled delivery models. Similarly, in low-resource settings like India, these models could reduce medication errors and improve patient adherence. Ultimately, strategic investment in pharmacy services is necessary to protect oncology patients from preventable adverse events.
MTM aims to optimize therapeutic outcomes by improving medication adherence and reducing adverse events or toxicities associated with complex chemotherapy regimens.
Common barriers include inadequate funding, a shortage of specialized staff, and low awareness among both patients and healthcare providers regarding the service.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Kathare J et al. Knowledge, attitudes, practices, and implementation of Medication Therapy Management in Selected Cancer Care Centres in Kenya. Int J Pharm Pract. 2026 Mar 29. doi: undefined. PMID: 41904657.
2. Jarab AS, et al. Pharmacists' knowledge and attitudes toward medication therapy management service and the associated challenges and barriers for its implementation. Saudi Pharm J. 2022 Jun;30(6):842-848. doi: 10.1016/j.jsps.2022.03.008.
3. Swarnakar R, Yadav SL. Cancer rehabilitation in India: Current status, scope, and future perspectives. World J Gastrointest Oncol. 2025 Oct 24;17(10).
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study on MTM in Kenyan cancer centres reveals high support but low utilization due to funding and staffing issues, highlighting a global need for MTM inte...
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
